Release of 50 new, drug-like compounds and their computational target predictions for open source anti-tubercular drug discovery
Published 2015 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
Release of 50 new, drug-like compounds and their computational target predictions for open source anti-tubercular drug discovery
Authors
Keywords
-
Journal
PLoS One
Volume 10, Issue 12, Pages e0142293
Publisher
Public Library of Science (PLoS)
Online
2015-12-09
DOI
10.1371/journal.pone.0142293
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- TB drug development: immunology at the table
- (2015) Carl Nathan et al. IMMUNOLOGICAL REVIEWS
- Ligand-Target Prediction by Structural Network Biology Using nAnnoLyze
- (2015) Francisco Martínez-Jiménez et al. PLoS Computational Biology
- Acquired Resistance of Mycobacterium tuberculosis to Bedaquiline
- (2014) Koen Andries et al. PLoS One
- Fueling Open-Source Drug Discovery: 177 Small-Molecule Leads against Tuberculosis
- (2013) Lluís Ballell et al. ChemMedChem
- Discovery of Q203, a potent clinical candidate for the treatment of tuberculosis
- (2013) Kevin Pethe et al. NATURE MEDICINE
- The ChEMBL bioactivity database: an update
- (2013) A. Patrícia Bento et al. NUCLEIC ACIDS RESEARCH
- Identification of Novel Imidazo[1,2-a]pyridine Inhibitors Targeting M. tuberculosis QcrB
- (2013) Katherine A. Abrahams et al. PLoS One
- Tetrahydropyrazolo[1,5-a]Pyrimidine-3-Carboxamide and N-Benzyl-6′,7′-Dihydrospiro[Piperidine-4,4′-Thieno[3,2-c]Pyran] Analogues with Bactericidal Efficacy against Mycobacterium tuberculosis Targeting MmpL3
- (2013) Modesto J. Remuiñán et al. PLoS One
- Identification of New Drug Targets and Resistance Mechanisms in Mycobacterium tuberculosis
- (2013) Thomas R. Ioerger et al. PLoS One
- Why are membrane targets discovered by phenotypic screens and genome sequencing in Mycobacterium tuberculosis?
- (2013) Robert C. Goldman TUBERCULOSIS
- Target Prediction for an Open Access Set of Compounds Active against Mycobacterium tuberculosis
- (2013) Francisco Martínez-Jiménez et al. PLoS Computational Biology
- Getting physical in drug discovery II: the impact of chromatographic hydrophobicity measurements and aromaticity
- (2011) Robert J. Young et al. DRUG DISCOVERY TODAY
- Benzothiazinones Are Suicide Inhibitors of Mycobacterial Decaprenylphosphoryl-β-d-ribofuranose 2′-Oxidase DprE1
- (2011) Claudia Trefzer et al. JOURNAL OF THE AMERICAN CHEMICAL SOCIETY
- ProtChemSI: a network of protein-chemical structural interactions
- (2011) O. V. Kalinina et al. NUCLEIC ACIDS RESEARCH
- Combinations of Protein-Chemical Complex Structures Reveal New Targets for Established Drugs
- (2011) Olga V. Kalinina et al. PLoS Computational Biology
- High-Resolution Phenotypic Profiling Defines Genes Essential for Mycobacterial Growth and Cholesterol Catabolism
- (2011) Jennifer E. Griffin et al. PLoS Pathogens
- Getting physical in drug discovery: a contemporary perspective on solubility and hydrophobicity
- (2010) Alan P. Hill et al. DRUG DISCOVERY TODAY
- Extended-Connectivity Fingerprints
- (2010) David Rogers et al. Journal of Chemical Information and Modeling
- ProBiS: a web server for detection of structurally similar protein binding sites
- (2010) J. Konc et al. NUCLEIC ACIDS RESEARCH
- Macrophage Apoptosis in Tuberculosis
- (2009) Jinhee Lee et al. YONSEI MEDICAL JOURNAL
Discover Peeref hubs
Discuss science. Find collaborators. Network.
Join a conversationBecome a Peeref-certified reviewer
The Peeref Institute provides free reviewer training that teaches the core competencies of the academic peer review process.
Get Started